Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Circulate Biotech is a New Zealand-based biotechnology company specializing in the development of epigenetic clocks to measure biological age. Spun out from the University of Otago, the company leverages advanced DNA methylation analysis to provide precise insights into the aging process and health status of animals, including livestock and wildlife. Their technology platform enables farmers and conservationists to make data-driven decisions regarding breeding, management, and longevity. While currently focused on animal health and agricultural applications, Circulate Biotech is also exploring the potential of its epigenetic profiling tools for human health and wellness monitoring.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Circulate Biotech.